D&B Summary

Paid-up Capital(INR)

8,612,400

Authorised Capital(INR)

9,000,000

Total Charges(INR)

Open Charges(INR)

D&B Reports
Compliance Report INR 14000.00 /- Report Status : Available Financial Year : 2018 Add To Cart \| Buy Report View Sample Report
Basic Report INR 6000.00 /- Report Status : Available Financial Year : 2018 Add To Cart \| Buy Report View Sample Report
Quick Check Report INR 2500.00 /- Report Status : Available Financial Year : 2018 Add To Cart \| Buy Report View Sample Report
Sectoral Risk Outlook (Industry Report) Sectoral Risk Outlook (Industry Report) Status : Unavailable Financial Year : NA View Sample Report

Business of interest

Low High

No. of search on company

News

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™ - PR Newswire UK

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™ PR Newswire UK

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Distribution Channel, Purchasing Pattern and Region - Global Forecast to 2025 - GlobeNewswire

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Distribution Channel, Purchasing Pattern and Region - Global Forecast to 2025 GlobeNewswire

The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025 - GlobeNewswire

The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025 GlobeNewswire

The Worldwide Osteoarthritis Therapeutics Industry is Expected to Reach $11 Billion by 2025 - ResearchAndMarkets.com - Business Wire

The Worldwide Osteoarthritis Therapeutics Industry is Expected to Reach $11 Billion by 2025 - ResearchAndMarkets.com Business Wire

Company Details

CIN.

U24230MH1946PLC005121

ROC Code

RoC-Mumbai

Date of Incorporation

10/08/1946

D&B D-U-N-S® Number

65-XXX-9075

Company Category

Company limited by Shares

Company SubCategory

Non-govt company

Class of Company

Public

Industry

WHOLESALE TRADE

Authorised Capital( INR)

9,000,000

Paid up Capital( INR)

8,612,400

Number of Members

1782

Registered Address

PHARMED HOUSE141 WALCHAND HIRACHAND MARG MUMBAI Mumbai City MH 400001 IN

Email Id

co.law@pharmed.in

Whether Listed or not

Unlisted

Last AGM

20/09/2018

Last Balance Sheet

31/03/2018

Registration Number

5121

Location

Potentially Related Company Based on Common Directorship

Company Name	Common Directors
SUNORA INVESTMENTS PRIVATE LIMITED	3
TRANSPORT CORPORATION OF INDIA LIMITED	1
TWIN PEAKS PHARMA CONSULTANTS PRIVATE LIMITED	1
BANGALORE MEDTRAIN LLP	1
BHORUKA AGRO BUSINESS PRIVATE LIMITED	1
BHORUKA COGEN POWER PRIVATE LIMITED	1
BHORUKA POWER CORPORATION LIMITED	1
BHORUKA STEEL AND SERVICES LIMITED	1
BHURUKA GASES INVESTMENTS INDIA PRIVATE LIMITED	1
BIT OLD STUDENTS GLOBAL ASSOCIATION	1
EUROMEDICA CONSULTANTS PRIVATE LIMITED	1
KIRLOSKAR ELECTRIC COMPANY LIMITED	1
MYRNA RESEARCH LABORATORIES PRIVATE LIMITED	1
PEGASUS HEALTH PRIVATE LIMITED	1
PHARMED MEDICARE PRIVATE LIMITED	1
PRABHU STRUCTURES HOLDINGS PRIVATE LIMITED	1
PRABHU STRUCTURES INVESTMENT INDIA PRIVATE LIMITED	1
PULSE HEALTHCARE PRIVATE LIMITED	1
SHAHAPUR POWER LIMITED	1
SUGRUHA ENGINEERS AND DEVELOPERS PRIVATE LIMITED	1

Charges

Charge Holder Name	Assets under charge	Charge Amount	Date of Creation	Date of Modification	Status

Principals/Signatory Details

Identification Number	Principal Names	Designation	Begin date	End date
00111187	SATYANARAYAN AGARWAL	Director	16/05/2013	05/03/2020
00625079	VENKATARAMANI KRISHNAMURTHY	Wholetime Director	06/05/2008	21/09/2018
00625261	NOSHIR BURJOR SHROFF	Wholetime Director	01/04/2008	21/09/2018
00767845	KRISHAN KUMAR AURORA	Director	01/08/2008	23/09/2018
02071123	JAGDISH CHINNAPPA	Director	25/06/2014	05/08/2018
02244628	SUNEET AURORA	Managing Director	01/08/2008	-
02300180	KASHMIRI LAL KAPOOR	Wholetime Director	01/08/2008	-